EyePoint Pharmaceuticals(EYPT) - 2024 Q1 - Quarterly Results
EyePoint Pharmaceuticals(EYPT)2024-06-26 13:25UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 08, 2024 EyePoint Pharmaceuticals, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 000-51122 26-2774444 (State or Other Jurisdiction (Commission File Number) (IRS Employer of Incorporation) Identification No .) 480 Pleasant Street Watertown, Massachusetts 02472 (Address ...